Cost-effectiveness of psychotherapy for cluster B personality disorders.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 20435967.
- Also identified by DOI 10.1192/bjp.bp.109.070482.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Recommendations on current clinical guidelines are informed by limited economic evidence. A formal economic evaluation of three modalities of psychotherapy for patients with cluster B personality disorders. A probabilistic decision-analytic model to assess the cost-effectiveness of out-patient, day hospital and in-patient psychotherapy over 5 years in terms of cost per recovered patient-year and cost per quality-adjusted life-year (QALY). Analyses were conducted from both societal and payer perspectives. From the societal perspective, the most cost-effective choice switched from out-patient to day hospital psychotherapy at a threshold of 12,274 euros per recovered patient-year; and from day hospital to in-patient psychotherapy at 113,298 euros. In terms of cost per QALY, the optimal strategy changed at 56,325 euros and 286,493 euros per QALY respectively. From the payer perspective, the switch points were at 9895 euros and 155,797 euros per recovered patient-year, and 43,427 euros and 561,188 euros per QALY. Out-patient psychotherapy and day hospital psychotherapy are the optimal treatments for patients with cluster B personality disorders in terms of cost per recovered patient-year and cost per QALY.
Medical subject headings
- Cost of Illness
- Personality Disorders
- Psychotherapy